Beyond Ozempic: Why Silicon Valley Is Turning to Experimental Peptides
Jasmine Sun on unregulated peptides moving from fringe biohacking to Silicon Valley mainstream, promising healing, focus, and optimization with little oversight
More Videos
CleanSpark Navigates the Energy Race Between Bitcoin Miners and AI Data Centers
Matt Schultz of CleanSpark discusses Bitcoin mining and AI infrastructure converge, energy demand dynamics, and the company’s position in the evolving market.
ServiceNow Unveils Autonomous Workforce to Transform Enterprise AI
Bhavin Shah of ServiceNow discusses how the new Autonomous Workforce AI automates tasks, integrates with Teams and Slack, and boosts workplace efficiency.
Angi Integrates with ChatGPT in First of Its Kind Marketplace Partnership
Angi is partnering with OpenAI to bring its home services marketplace directly into ChatGPT, allowing users to go from questions to booking local pros.
Will New York’s BNPL Crackdown Reshape Short Term Consumer Credit?
New York is rolling out mandatory licensing for buy now pay later providers, a move that could reshape fintech regulation and set a national standard.
Go Inside On Running’s Rapid Rise From Swiss Start Up To Global Performance Brand
On Running’s co-founder David Allemann discusses the brand’s rapid growth, innovation in performance tech, and how it is competing with global giants.
Nvidia Momentum Drives Tech Rally As Investors Bet Big On AI
Tech stocks are rallying on strong earnings and massive AI investment. Investors are watching Nvidia & hyperscaler spending for clues on how long it will last.
